U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231835) titled 'Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons' on Nov. 14.
Brief Summary: The primary aim of this registry is to systematically collect and analyze real-world data on all patients undergoing PCI with the Protege paclitaxel-eluting DCB to evaluate procedural outcomes, long-term efficacy, and safety across various clinical indications. This registry aims to assess the clinical effectiveness of DCB therapy across diverse patient populations, including those with stable coronary artery disease (CAD) and acute coronary syndromes (ACS), as well as various lesion subsets, encompassing (but not limited to) ...